We are live on ! Find out more
WST icon

West Pharmaceutical
WST

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374 → 406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4% → 91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$71.8M
2
Brown Advisory
Brown Advisory
Maryland
+$26.3M
3
Morgan Stanley
Morgan Stanley
New York
+$25.4M
4
BlackRock
BlackRock
New York
+$24.6M
5
N
Nuveen
North Carolina
+$24.4M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$118M
2
UIM
USS Investment Management
United Kingdom
-$76.2M
3
EAM
Eagle Asset Management
Florida
-$39.7M
4
CTA
Carillon Tower Advisers
Florida
-$29.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$22.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Carson Wealth (CWM LLC)
351
Carson Wealth (CWM LLC)
Nebraska
$116K – – –
PCG
352
Private Capital Group
Connecticut
$97K +$33.6K +244 +56%
RCAG
353
Rehmann Capital Advisory Group
Michigan
$92K – – –
Group One Trading
354
Group One Trading
Illinois
$76K -$34.4K -250 -32%
QCG
355
Quadrant Capital Group
Ohio
$76K – – –
HFM
356
Harvest Fund Management
China
$70K +$68.2K +495 New
ST
357
Smithfield Trust
Pennsylvania
$63K – – –
TF
358
Tompkins Financial
New York
$54K – – –
ASN
359
Advisory Services Network
Georgia
$49K – – –
SPIA
360
Steward Partners Investment Advisory
New York
$47K +$1.65K +12 +4%
BCA
361
Berman Capital Advisors
Georgia
$42K – – –
TIM
362
Tortoise Investment Management
New York
$37K -$826 -6 -2%
Northwestern Mutual Wealth Management
363
Northwestern Mutual Wealth Management
Wisconsin
$34K +$964 +7 +3%
FGAM
364
Financial Gravity Asset Management
Texas
$33K -$104K -757 -76%
AS
365
Altshuler Shaham
Israel
$33K +$20K +145 +165%
FDCDDQ
366
Federation des caisses Desjardins du Quebec
Quebec, Canada
$31.8K +$18.9K +137 +157%
SFSIG
367
San Francisco Sentry Investment Group
California
$31K -$688 -5 -2%
GAM
368
Gemmer Asset Management
California
$24K – – –
SIAS
369
Shine Investment Advisory Services
Colorado
$24K – – –
GRP
370
Global Retirement Partners
California
$21K – – –
FIA
371
FNY Investment Advisers
New York
$21K +$20.7K +150 New
CIA
372
CSat Investment Advisory
Michigan
$20K +$2.75K +20 +16%
LF
373
Lee Financial
Texas
$18K -$2.75K -20 -13%
CFA
374
Carroll Financial Associates
North Carolina
$18K – – –
FPS
375
Fieldpoint Private Securities
Connecticut
$18K – – –
13 14
15
16 17

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.